Download definitions of infection severity

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

African trypanosomiasis wikipedia , lookup

Rotaviral gastroenteritis wikipedia , lookup

Toxocariasis wikipedia , lookup

Antibiotics wikipedia , lookup

Tuberculosis wikipedia , lookup

Staphylococcus aureus wikipedia , lookup

Microbicides for sexually transmitted diseases wikipedia , lookup

Traveler's diarrhea wikipedia , lookup

Leptospirosis wikipedia , lookup

Salmonella wikipedia , lookup

Carbapenem-resistant enterobacteriaceae wikipedia , lookup

HIV wikipedia , lookup

Cryptosporidiosis wikipedia , lookup

Toxoplasmosis wikipedia , lookup

Norovirus wikipedia , lookup

Pandemic wikipedia , lookup

Hookworm infection wikipedia , lookup

Gastroenteritis wikipedia , lookup

Middle East respiratory syndrome wikipedia , lookup

Sexually transmitted infection wikipedia , lookup

Neisseria meningitidis wikipedia , lookup

West Nile fever wikipedia , lookup

Herpes simplex wikipedia , lookup

Trichinosis wikipedia , lookup

Marburg virus disease wikipedia , lookup

Herpes simplex virus wikipedia , lookup

Henipavirus wikipedia , lookup

Sarcocystis wikipedia , lookup

Anaerobic infection wikipedia , lookup

Schistosomiasis wikipedia , lookup

Chickenpox wikipedia , lookup

Hepatitis C wikipedia , lookup

Dirofilaria immitis wikipedia , lookup

Clostridium difficile infection wikipedia , lookup

Candidiasis wikipedia , lookup

Oesophagostomum wikipedia , lookup

Coccidioidomycosis wikipedia , lookup

Lymphocytic choriomeningitis wikipedia , lookup

Hepatitis B wikipedia , lookup

Human cytomegalovirus wikipedia , lookup

Neonatal infection wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Transcript
DEFINITIONS OF INFECTION SEVERITY
Life-threatening/Fatal:
1. Septic shock
2. Any infection clearly linked to death within 2 weeks
3. Life-threatening/fatal infections include:
• Any proven/probable pulmonary or disseminated mold infection
• CMV pneumonitis (CXR infiltrate + recovery of virus in BAL specimen or lung biopsy evidence)
• Disseminated CMV
• Respiratory virus pneumonitis Influenza/RSV/Parainfluenza virus of lung (CXR infiltrate +
recovery)
• Disseminated aspergillus
• HHV-6 in central nervous system (CNS)
• Toxoplasma in brain or CNS
• PCP in lung
Severe:
1.
2.
3.
4.
•
•
•
•
•
•
•
•
•
•
•
•
•
Deep tissue (invasive) infection requiring IV or oral antibiotics used to treat infection
Any infection requiring hospitalization, if outpatient at onset
Any infection leading to need for oxygen, pressors or fluids to support BP, or intubation
Severe infections include:
Any proven or probable sinus (limited) mold infection
Pulmonary nodules that decrease in size after a minimum 4 week course of antifungal
medications active against Aspergillus
Any Bacteremia, catheter-related bloodstream infection (excluding Coagulase negative
staphylococcus and Diptheroids which are MODERATE infections)
Any infection that requires adjunctive surgical intervention
Any Pneumonia not requiring ventilatory support (see life-threatening/fatal category for specific
viral pneumonias)
Upper airway (limited) respiratory viruses (firm diagnosis)
CMV antigenemia or PCR positivity treated with an 8 week course of antiviral therapy
Hemorrhagic cystitis due to BK virus
Pseudomembranous colitis due to C. difficile
Typhlitis
Osteomyelitis
Meningitis
Disseminated or complicated zoster (i.e., ophthalmic)
BMT CTN Data Coordinating Center
Medical College of Wisconsin Π8701 Watertown Plank Rd. ΠMilwaukee WI 53226 Π414-456-8325 ΠFax: 414-456-6530
The EMMES Corporation Π401 N. Washington Street ΠSuite 700 ΠRockville MD 20850 Π301-251-1161 ΠFax: 301-251-1355
National Marrow Donor Program® Œ 3001 Broadway Street NE Œ Suite 500 Œ Minneapolis MN 55413 Œ 612-362-3425 Œ Fax: 612-627-8125
DEFINITIONS OF INFECTION SEVERITY
Page 2 of 2
Moderate:
1. IV or Oral antibiotics used to treat infection with complete resolution within 14 days
2. No need for hospitalization specifically to treat infection
3. If already hospitalized, no need for supplemental oxygen, pressors or fluids to support BP, or
intubation
4. Moderate infections include:
• Many gram positive Bacteremias (Coagulase negative staphylococcus, Corynebacterium,
Proprionibacterium acnes)
• Any catheter site infection
• Urinary tract infection
• Soft tissue infection/infected wound (not extensive, not necrotizing)
• Localized/dermatomal zoster
• Oral HSV
• Esophagitis due to HSV or candida
• Sinusitis, bacterial
• Infectious diarrhea, including uncomplicated C. difficile
Disseminated Infections:
1. Two or more non-contiguous sites with the SAME organism
2. A disseminated infection can occur at any level of severity
Recurrence Intervals to Determine Whether an Infection is the Same or New:
1.
2.
3.
4.
5.
6.
7.
8.
9.
CMV, HSV: 2 months (≤ 60 days)
VZV, HZV: 2 weeks (≤ 14 days)
Bacterial, non-C. difficile: 1 week (≤ 7 days)
Bacterial, C. difficile: 1 month (≤ 30 days)
Yeast: 2 weeks (≤ 14 days)
Molds: 3 months (≤ 90 days)
Heliobacter: 1 year (≤ 365 days)
Adenovirus, Enterovirus, Influenza, RSV, Parainfluenza, Rhinovirus: 2 weeks (≤ 14 days)
Polyomavirus: 2 months (≤ 60 days)
For infections coded as “Disseminated,” any previous infection with the same organism but different site
within the recurrence interval for that organism will be counted as part of the disseminated infection.
The Following Should NOT be Reported as an Infection:
1.
2.
3.
4.
Fever of undetermined origin
Upper respiratory infections, presumed viral
Potential infections where antibiotics were given but no infectious etiology identified
Stool candida
BMT CTN Data Coordinating Center
Medical College of Wisconsin Π8701 Watertown Plank Rd. ΠMilwaukee WI 53226 Π414-456-8325 ΠFax: 414-456-6530
The EMMES Corporation Π401 N. Washington Street ΠSuite 700 ΠRockville MD 20850 Π301-251-1161 ΠFax: 301-251-1355
National Marrow Donor Program® Œ 3001 Broadway Street NE Œ Suite 500 Œ Minneapolis MN 55413 Œ 612-362-3425 Œ Fax: 612-627-8125